{"entity":{"id":"minuteman-therapeutics","kind":"company","name":"Minuteman Therapeutics","aka":["Minuteman Tx"],"tldr":"Minuteman Therapeutics develops oncolytic viruses engineered against an individual patient's tumour, matching the virus to the biology of that person's cancer.","summary":"Oncolytic viruses infect and kill cancer cells and alert the immune system to them; talimogene laherparepvec is the approved example. Minuteman's stated approach is personalised: an oncolytic virus designed against the individual patient's tumour rather than one product for all. It is an Even One Ventures portfolio company with no published trials.","asOf":"2026-09-10","links":[{"label":"Official website","url":"https://minuteman.bio/"},{"label":"Even One Ventures portfolio","url":"https://evenone.ventures/"}],"tags":["startup","evenone-portfolio","oncology"],"related":[],"cancers":[],"sections":[],"technologies":["oncolytic-virus"],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"hq":"United States (head office not published)","country":"US","companyType":"biotech","website":"https://minuteman.bio/","stage":"startup","investors":["evenone-ventures"],"funding":[]},"route":"/companies/minuteman-therapeutics/","neighbours":{"technology":[{"id":"oncolytic-virus","kind":"technology","name":"Oncolytic viruses","route":"/technologies/oncolytic-virus/"}],"company":[{"id":"evenone-ventures","kind":"company","name":"Even One Ventures","route":"/companies/evenone-ventures/"}]}}